Investor Presentaiton
37
Experienced Executive Team and Board of Directors
•
•
J. Joseph Kim, Ph.D.
President & CEO
Decades of biotech/pharma
management
Merck: hepatitis A and B
vaccines manufacturing;
HIV vaccine (Ad5) R&D
Board of
Directors
Peter Kies
CFO
Jacqueline Shea, Ph.D.
COO
•
Ernst & Young
•.
Former CEO/COO of Aeras
•
Experience with growth
companies
•
Held management positions
at Emergent BioSolutions and
Microscience Ltd.
•
Laurent Humeau, Ph.D.
CSO
Extensive R&D leadership exp. in
vaccine, cell and gene therapy
developments in private biotech and
mid-cap companies
Led Translational Research, Human
Therapeutics Division for Intrexon
Simon X. Benito
Chairman of the Board, Former SVP, Merck Vaccine Division
J. Joseph Kim, Ph.D.
President & CEO, INOVIO Pharmaceuticals
Ann. C. Miller, M.D.
Former Head of Sanofi Oncology Global Marketing
Jay Shepard
Former President & CEO, Aravive
David B. Weiner, Ph.D.
Executive VP, Director, Vaccine Center, The Wistar Institute
Wendy L. Yarno, Ph.D.,
Former Executive VP and Chief Marketing Officer, Merck
Lota S. Zoth
Former CFO, MedImmune
INOVIO
POWERING DNA MEDICINESView entire presentation